Skip to main content
Daily Report

Daily Cosmetic Research Analysis

11/25/2025
3 papers selected
3 analyzed

Three studies stand out today in cosmetic science: a mechanistic-to-clinical investigation shows a human umbilical cord–MSC secretome promotes hair growth via PI3K/AKT/mTOR-driven methylthioadenosine synthesis; an observational analysis of 101,562 rhinoplasty patients proposes the BLAKE mnemonic to predict revision risk; and a novel magnetic eutectic microextraction method enables ultra-trace multi-metal screening in cosmetic essential oils by ICP-OES.

Summary

Three studies stand out today in cosmetic science: a mechanistic-to-clinical investigation shows a human umbilical cord–MSC secretome promotes hair growth via PI3K/AKT/mTOR-driven methylthioadenosine synthesis; an observational analysis of 101,562 rhinoplasty patients proposes the BLAKE mnemonic to predict revision risk; and a novel magnetic eutectic microextraction method enables ultra-trace multi-metal screening in cosmetic essential oils by ICP-OES.

Research Themes

  • Cell-free regenerative therapy for hair loss
  • Risk stratification in aesthetic surgery
  • Analytical safety testing for cosmetic ingredients

Selected Articles

1. The human umbilical cord-mesenchymal stem cell secretome regulates hair growth and cycle transition by promoting methylthioadenosine synthesis via the PI3K/AKT/mTOR pathway.

76Level IIRCT
Stem cell research & therapy · 2025PMID: 41287018

Using multi-omics across murine, ex vivo, and cellular systems plus a 3‑month double-blind clinical study, hUC‑MSC secretome accelerated telogen-to-anagen transition and thickened hair via PI3K/AKT/mTOR-driven methylthioadenosine synthesis. Clinically, it increased hair density and diameter without scalp adverse events.

Impact: Links a defined metabolic node (methylthioadenosine) and canonical signaling to clinically observed hair growth, advancing a cell-free regenerative approach for alopecia.

Clinical Implications: Suggests a non-invasive, cell-free topical/meso-therapy candidate for hair loss with an early safety signal; supports biomarker-driven trials targeting PI3K/AKT/mTOR–MTA axis.

Key Findings

  • SCT accelerated telogen-to-anagen transition and increased hair thickness/length in mice and ex vivo follicles.
  • Mechanism: activation of PI3K/AKT/mTOR in hair matrix cells increased methylthioadenosine synthesis via cysteine/methionine metabolism.
  • In a 3‑month double-blind clinical study, hair density and mean diameter increased without scalp adverse reactions.

Methodological Strengths

  • Integrated untargeted metabolomics and phosphoproteomics across in vivo, ex vivo, and cell systems.
  • Included a double-blind clinical study to translate mechanistic findings to humans.

Limitations

  • Clinical sample size and randomization/allocation details were not specified; durability beyond 3 months is unknown.
  • Dose-response, formulation, and long-term safety were not evaluated.

Future Directions: Conduct adequately powered, pre-registered RCTs with standardized endpoints; define pharmacodynamics of the MTA axis; identify responder subgroups and optimize dosing/formulation.

BACKGROUND: The human umbilical cord (hUC)-mesenchymal stem cell (MSC) secretome (SCT) is a cell-free therapy that may emerge as a novel therapeutic strategy for hair loss prevention. Here, we aimed to elucidate the underlying mechanisms through which SCT regulates hair growth and cycle transition. METHODS: Using C57BL/6 mice, ex vivo follicles, and cell experiments, we studied the effects and mechanisms of SCT on hair growth and cycling using untargeted metabolomics and phosphoproteomics. A three-month double-blind clinical study was conducted to validate the effects of SCT on human hair. RESULTS: SCT promotes the telogen-to-anagen transition, hair thickening, and elongation of the vibrissae in mice; regulates dermal papilla cells and hair matrix cells through cysteine and methionine metabolism; and stimulates methylthioadenosine synthesis in hair matrix cells by activating the PI3K/AKT/mTOR signaling pathway. Clinical studies demonstrated that SCT increased human hair density and average hair diameter. Scalp physiological tests and subjective feedback indicated no related adverse reactions on the scalp or hair. CONCLUSIONS: SCT promoted hair growth, thickening, and the hair follicle cycle via the PI3K/AKT/mTOR signaling pathway. This research provides a basis for the application of cell-free alternatives in hair care and hair loss prevention.

2. Current Predictors of Revision at Time of Primary Rhinoplasty.

67.5Level IIICohort
Aesthetic plastic surgery · 2025PMID: 41286173

In a TriNetX cohort of 101,562 primary rhinoplasty patients with ≥3 years since surgery, social exclusion, personality disorders, prior fillers, and anxiolytic/sedative dependence strongly increased revision risk. Authors propose the BLAKE mnemonic to modernize patient selection beyond SIMON.

Impact: Large-scale, data-driven risk stratification offers actionable predictors to reduce dissatisfaction and revision in cosmetic rhinoplasty.

Clinical Implications: Incorporate BLAKE screening (social isolation, personality disorder, anxiolytics/sedatives, cosmetic focus, prior fillers) into preoperative counseling and optimize indication to reduce revision risk.

Key Findings

  • Revision risk increased 16.8× with social exclusion/rejection and 5.36× with personality disorders.
  • History of subcutaneous fillers (3.45×) and dependence on anxiolytics/sedatives (2.64×) were strong predictors; male sex (1.38×) and anxiolytic use (1.16×) modestly increased risk.
  • Married status, BMI > 30, older surgical age, and deviated septum diagnosis were associated with lower revision rates; proposed BLAKE mnemonic for screening.

Methodological Strengths

  • Very large sample (n=101,562) with minimum 3-year postoperative window.
  • Multivariable Cox proportional hazards including 115 covariates enables robust adjustment.

Limitations

  • Retrospective EHR-based analysis susceptible to coding bias and residual confounding.
  • Lacks external validation and patient-reported satisfaction/psychometric outcomes.

Future Directions: Prospectively validate BLAKE, integrate standardized psychometric screening, and assess surgical technique variables and filler types/locations.

BACKGROUND: Before primary rhinoplasty, it is crucial to identify patients whose concerns may not be adequately addressed by surgery. In 1999, Gorney and Martello introduced SIMON to describe patients who may be unsatisfied: single, immature, male, overly expectant, and narcissistic. This paper advocates for an evidence-based mnemonic to enhance patient selection. METHODS: TriNetX database medical records were queried for patients who underwent primary rhinoplasty at least three years ago at ≥ 15 years old. A Cox proportional hazards model quantified relationships between 115 patient variables, including SIMON-like characteristics, and risk of revision rhinoplasty. RESULTS: Of 101,562 patients, more female patients underwent revision rhinoplasty than male patients (p = 0.062). Revision risk was 16.8× higher with social exclusion/rejection; 5.36× higher with personality disorders; 3.45× higher with history of subcutaneous filler injections; 2.64× higher with anxiolytic or sedative dependence; 1.38× higher with male sex; and 1.16× higher with anxiolytic use. "Married" relationship status, BMI > 30, older age at surgery, and diagnosed deviated septum were negative associations with revision rhinoplasty. CONCLUSION: In the current day, additional nuance in social relationships, surgical history, psychiatric diagnosis, and surgical indication may be required to predict revision rhinoplasty. We propose an acronym, BLAKE: Borderline/personality disorders, Lonely/social exclusion, Anxiolytics/sedatives, Kosmetik focus, and previous Enhancement with fillers. BLAKE captures the most salient predictors of revision at the time of primary rhinoplasty, updating the SIMON acronym to be non-gendered and nonreligious. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .

3. Co-based magnetic eutectic mixture for the extraction of trace metals in essential oils used in cosmetic industry prior to analysis by inductively coupled plasma optical emission spectrometry.

67.5Level IVCase series
Analytica chimica acta · 2026PMID: 41285539

The authors introduce a CoCl2·6H2O:ethylene glycol (1:2) magnetic eutectic mixture enabling 3‑minute ultrasound-assisted microextraction of seven metals from essential oils, achieving LODs of 0.05–5.4 µg/kg prior to ICP‑OES. This rapid, green, and sensitive method strengthens safety surveillance in cosmetic raw materials.

Impact: Provides a practical, scalable, and greener sample-prep innovation for multi-metal surveillance in cosmetic ingredients, addressing a pressing regulatory and public health need.

Clinical Implications: Enables more sensitive and efficient quality control of cosmetic essential oils, potentially reducing consumer exposure to toxic metals and informing regulatory compliance.

Key Findings

  • Developed a Co-based magnetic eutectic mixture (CoCl2·6H2O:ethylene glycol, 1:2) for USAEME of metals from essential oils.
  • Optimized conditions: 11 g sample, 59 μL MEM, 3 min extraction with ultrasound; achieved LODs of 0.05–5.4 μg/kg for Al, Cd, Cr, Cu, Mn, Pb, and Zn.
  • Method is rapid, sensitive, and environmentally sustainable, enabling simultaneous multi-metal ICP‑OES analysis.

Methodological Strengths

  • Multivariate optimization of extraction parameters with very short extraction time (3 min).
  • Magnetic eutectic mixture enables efficient phase separation and preconcentration for ICP‑OES.

Limitations

  • Validated on essential oils; performance in complex finished cosmetic matrices remains to be tested.
  • Requires interlaboratory validation and comparison with standardized reference methods.

Future Directions: Extend to diverse cosmetic matrices (creams, lotions), conduct interlaboratory studies, and integrate certified reference materials to establish routine QC protocols.

BACKGROUND: Cosmetic products are widely used today and are often associated with a healthy lifestyle. However, their widespread application and the presence of potentially toxic substances have raised increasing concerns regarding their impact on human health. Among these substances, metals are particularly hazardous due to their ability to penetrate the skin and cause adverse health effects, even at very low concentrations. Therefore, the development of novel and reliable methodologies for the determination of trace metals in cosmetics is of great importance for ensuring product safety. RESULTS: A new analytical method based on a magnetic eutectic mixture (MEM) ultrasound-assisted emulsification-micro-extraction (USAEME) followed by inductively coupled plasma optical emission spectrometry (ICP OES) for trace metals in cosmetics has been developed. The extraction procedure was optimized using a multivariate approach. The method was evaluated under optimized extraction conditions (i.e., sample mass, 11 g; MEM volume, 59 μL; extraction time, 3 min and ultrasound as dispersive mode). Limits of detection from 0.05 to 5.4 μg kg SIGNIFICANCE: A novel, rapid, sensitive, and environmentally sustainable method was developed for the simultaneous determination of Al, Cd, Cr, Cu, Mn, Pb, and Zn in essential oil samples using ICP OES. The methodology incorporated a preconcentration step via USAEME employing a new designed Co-based MEM (i.e., cobalt (II) chloride hexahydrated:ethylene glycol, 1:2).